drugset / Trial / NCT01408355

A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.

NCT01408355 ↗

Phase 1 Completed 5 enrolled Pfizer
RandomizedSingle-groupOpen-labelBasic science

Summary

To investigate the pharmacokinetics of PF-06273588 following administration of a micro-dose via both intravenous and oral routes.

Timeline

Start
2011-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06273588 Unknown 50 ug Intravenous

Indications

No indication recorded.